Certified by Founder Lodge 
                                        
                                        Evommune
 
                                                 United States  -  Palo Alto, California 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $50,000,000
                                            0 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Chronic inflammatory diseases are the most significant cause of death in the world, and those who live with them have a reduced quality of life.
Many immunology-focused medications give pa
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| April, 27 ,2023 | Series B | $50,000,000 | |
| June, 29 ,2023 | Series B | $7,500,000.00 | |
| November, 01 ,2024 | Series C | $115,000,000.00 | 
                                                
 Andera Partners
                                                                                
                                                                            
 EQT Life Sciences
                                                                                
                                                                            
 Arix Bioscience plc
                                                                                
                                                                            
 Amplitude Ventures
                                                                                
                                                                            
 Symbiosis
                                                                                
                                                                            
 Pivotal bioVenture Partners
                                                                                
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)